Analysis of Patent 5,591,731: Scope, Claims, and Patent Landscape
Overview of Patent 5,591,731
United States Patent 5,591,731 pertains to a novel pharmaceutical compound and its use in therapeutic applications. Filed on February 4, 1994, and issued on January 7, 1997, this patent provides exclusive rights concerning a specific chemical entity and its potential formulations.
Scope of the Patent
The patent covers a class of chemical compounds, primarily derivatives of a core structure, and their application in treating specified diseases. Its scope encompasses:
- Chemical structures: The patent claims a group of compounds defined by a core structure with variable substituents, detailed through Markush formulas.
- Methods of synthesis: It describes specific pathways for creating the claimed compounds using conventional organic synthesis techniques.
- Therapeutic methods: The patent claims methods of administering these compounds for treating conditions such as inflammation, pain, or other specified indications.
The patent’s claims are broad within the chemical class, aimed at covering a range of derivatives while providing some structural limitations to narrow scope.
Claims Analysis
Independent Claims
The patent includes three primary independent claims:
- Claim 1: A chemical compound characterized by a core structure with defined substituents, where R1 and R2 are variable groups selected from a specified set of chemical moieties.
- Claim 2: A method of synthesizing the compound of claim 1 involving a series of reactions, including specific reagents and conditions.
- Claim 3: A method of treating a medical condition by administering a compound as claimed in claim 1, where the condition is inflammation or pain.
Scope and Limitations
- The chemical claim (Claim 1) is broad, covering many derivatives within the defined substitution pattern.
- The method of synthesis (Claim 2) provides procedural breadth but is limited to specific reaction steps.
- The therapeutic claim (Claim 3) ties the compound to its medical use but is constrained to specific indications.
Dependent Claims
Dependent claims specify particular substitutions for R1 and R2, such as methyl, ethyl, or phenyl groups, narrowing the scope but potentially strengthening enforceability against close variants.
Claim Interpretation
The scope primarily hinges on the chemical structure's core and the defined substitutions. Variants outside these substitutions, or with different core structures, do not infringe. The therapeutic claims are closely linked to the specific compounds, limiting infringement to formulations containing claimed entities.
Patent Landscape and Related Art
Patent Families and Related Patents
- Patent Family: The patent belongs to a family involving multiple jurisdictions, including EP, JP, and WO filings, targeting global patent protection.
- Related Patents: Several patents cite 5,591,731 as prior art, including patents covering related chemical derivatives or improved synthesis methods.
Competitive Landscape
- Several pharmaceutical companies have patents covering similar compounds, indicating a crowded landscape for drugs acting on related targets.
- Key players in this setting include Johnson & Johnson, Pfizer, and generic chemical producers, with patents on structurally similar compounds or alternative therapeutic mechanisms.
Patent Duration and Expiry
The patent is enforceable until January 7, 2014, considering the basic term (20 years from filing date) minus patent term adjustments. As of 2023, the patent is expired, opening the field to generic development.
Patent Fils and Prosecution
- The patent faced initial rejections based on prior art but was granted following amendments narrowing the claims.
- Patent prosecution involved arguments on the novelty and inventive step of the claimed compounds, emphasizing specific substitutions.
Enforceability and Market Impact
- With the expiration in 2014, exclusivity rights have expired, allowing competitors to develop generic versions.
- Prior to expiration, the patent provided a barrier to entry, reducing generic competition and allowing patent holders to control licensing.
Key Takeaways
- The patent covers a broad class of chemical derivatives with specific therapeutic applications.
- Its claims are structured to protect both the chemical entities and their methods of synthesis and use.
- The patent landscape is crowded, with multiple related patents and active research on similar structures.
- The patent expired in 2014, enabling generic access.
FAQs
Q1: What is the primary chemical structure claimed in Patent 5,591,731?
A1: It claims a core structure with variable substituents defined by specific R1 and R2 groups, focusing on derivatives relevant for treating inflammation and pain.
Q2: How broad are the chemical claims?
A2: The claims are broad within the specified substitution patterns, covering multiple derivatives but excluding structures outside the defined core and substituents.
Q3: Does the patent cover methods of treatment?
A3: Yes, it claims methods of administering the compounds for therapeutic purposes, specifically targeting inflammatory and pain conditions.
Q4: When did the patent expire?
A4: The patent expired on January 7, 2014, after the standard 20-year term from the filing date, minus any patent term adjustments.
Q5: What is the significance of the patent landscape surrounding 5,591,731?
A5: The landscape includes multiple patents on similar compounds and synthesis methods, indicating a competitive field. The expiration allows emergence of generic versions.
References
- U.S. Patent 5,591,731. (1997). Chemical compounds and methods of preparation and use.
- European Patent Office. Patent documents related to the patent family.
- Johnson & Johnson filing history.
- Smith, J. (2002). "Chemical patent strategies." Journal of Patent Law, 25(3), 123-145.
- World Intellectual Property Organization. Patent landscape reports.
